Q2 2016 Holdings
Filed 2016-08-12 | 63 holdings | $38.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Nuvasive Inc(NUVAGBP) | COM | 670704105 | $9.0K | 150,000 | 0.0% |
| Alexion Pharmaceuticals Inc(ALXN) | COM | 015351109 | $10.5K | 90,000 | 0.0% |
| Ophthotech Corp | COM | 683745103 | $11.0K | 215,000 | 0.0% |
| GW Pharmaceuticals PLCPut | ADS | 36197T103 | $11.9K | 130,000 | 0.0% |
| Spdr S&P 500 ETF TR(SPY)Put | TR UNIT | 78462F103 | $20.9K | 100,000 | 0.1% |
| Spdr Series Trust(XBI)Put | S&P BIOTECH | 78464A870 | $21.6K | 400,000 | 0.1% |
| Ishares TR(IWM)Put | RUSSELL 2000 ETF | 464287655 | $40.2K | 350,000 | 0.1% |
| Ascendis Pharma A S(ASND) | SPONSORED ADR | 04351P101 | $1.3M | 100,000 | 3.5% |
| Biocryst Pharmaceuticals(BCRX) | COM | 09058V103 | $4.8M | 1,700,000 | 12.6% |
| Biogen Inc(BIIB) | COM | 09062X103 | $7.3M | 30,000 | 19.0% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $7.6M | 325,000 | 19.9% |
| Conmed Corp(CNMD) | COM | 207410101 | $8.4M | 175,000 | 21.9% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $8.6M | 110,000 | 22.4% |